Clinical Trial Update: Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes [Phase 4]

View source ↗

Summary

This update reports the results of a Phase 4 trial comparing repaglinide to metformin in non-obese adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• metformin (metformin)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED